InsiderTrades

Form 4 for ALT Altimmune, Inc.

Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-01 · accession 0001104659-24-001463 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-04 2024-01-01 ALT Jordt Raymond M Chief Business Off M - OptEx $0.00 +9,375 11.2K +512% $0
D 2024-01-04 2024-01-01 ALT Jordt Raymond M Chief Business Off F - Tax $11.25 -2,503 8,704 -22% -$28.2K
D 2024-01-04 2024-01-01 ALT Jordt Raymond M Chief Business Off M - OptEx $0.00 -9,375 28.1K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 2024-01-01 M A 9,375 $0.00 11,207 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
2 Common Common Stock, par value $0.0001 2024-01-01 F D 2,503 $11.25 8,704 D — —
3 Derivative Restricted Stock Units 2024-01-01 M D 9,375 $0.00 28,125 D — · — to — 9,375 Common Stock, par value $0.0001 (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs become vested and exercisable over four (4) years with 25% of the shares vesting on January 1, 2024, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.